Impact of hospital volume on outcomes of percutaneous ASD/PFO closure in pediatric patients

@article{Bhatt2018ImpactOH,
  title={Impact of hospital volume on outcomes of percutaneous ASD/PFO closure in pediatric patients},
  author={Parth Bhatt and Achint A. Patel and Varun Kumar and Anusha Lekshminarayanan and Viranchi Patel and Srilatha Alapati and Zeenia C. Billimoria},
  journal={World Journal of Pediatrics},
  year={2018},
  volume={14},
  pages={364-372}
}
BackgroundWe investigated the effect of hospital volume on percutaneous closure of atrial septal defect/patent foramen ovale (ASD) among pediatric patients.MethodsWe identified patients undergoing percutaneous closure of ASD with device using International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) procedure code 35.52 from the National Inpatient Sample, years 2002–2011. Patients with age ≤ 18 years and primary diagnosis code 745.5 for ASD were included. Hospital… 

References

SHOWING 1-10 OF 19 REFERENCES

Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: A 10‐years us perspective

  • Vikas SinghA. Badheka E. de Marchena
  • Medicine
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • 2015
TLDR
Low hospital volume is associated with an increased composite (mortality and procedural complications) adverse outcome following ASD/PFO closure, and implementation of the current guidelines for minimum required annual hospital volume to improve clinical outcomes is warranted.

Early Complications After Percutaneous Closure of Atrial Septal Defect in Infants with Procedural Weight Less than 15 kg

TLDR
Percutaneous ASD device closure can be performed safely in low-weight infants with a risk of post-procedural in-hospital complications comparable to larger/older children, Nevertheless, careful considerations of the indications to device closure is needed, particularly in children with larger ASD, as recommended by the current international guidelines for ASD closure.

Impact of Annual Operator and Institutional Volume on Percutaneous Coronary Intervention Outcomes: A 5-Year United States Experience (2005–2009)

TLDR
Overall in-hospital mortality after PCI was low, and an increase in operator and institutional volume of PCI was found to be associated with a decrease in adverse outcomes, length of hospital stay, and cost of hospitalization.

Transcatheter Closure of Atrial Septal Defect: Does Age Matter?

TLDR
The basis for device closure in small children and elderly patients with ASD is reviewed and an overview of the frequently encountered problems is provided.

The Clinical Course of Patients With Atrial Septal Defects

TLDR
It is concluded that atrial septal defects < 6 mm typically close spontaneously, and ASDs measuring 6 - 9 mm may regress in infants and children.

Long-term follow up of secundum atrial septal defect closure with the amplatzer septal occluder.

TLDR
Data indicate that for up to 120 months of patient follow-up, the ASO continues to be a safe device, andResidual shunts and arrhythmias have low incidence post-ASO placement.

Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association.

TLDR
The objective of the present writing group was not only to provide the reader with an inventory of diagnostic catheterization and interventional treatment options but also to critically review the literature and formulate relative recommendations that are based on key opinion leader expertise and level of evidence.